Evidence map›Paper›PMID 34287478›Full record

ArticleClinics (Sao Paulo, Brazil)

Use of medicines in São Paulo, Brazil, and State Health Care Coverage, 2003 and 2015.

Camila Nascimento Monteiro, Felipe Tadeu Carvalho Santos, Karen Sarmento Costa, Marilisa Berti de Azevedo Barros, Chester Luiz Galvão Cesar, Moisés Goldbaum

Open access · goldAbstract read
In one paragraph

Article in Clinics (Sao Paulo, Brazil). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Camila Nascimento MonteiroDepartamento de Medicina Preventiva, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo, SP, BR.ORCID http://orcid.org/0000-0002-0121-0398
Felipe Tadeu Carvalho SantosFaculdade de Ciencias Medicas, Universidade Estadual de Campinas, Campinas, SP, BR.ORCID http://orcid.org/0000-0003-1371-5403
Karen Sarmento CostaFaculdade de Ciencias Medicas, Universidade Estadual de Campinas, Campinas, SP, BR.ORCID http://orcid.org/0000-0002-2218-6024
Marilisa Berti de Azevedo BarrosFaculdade de Ciencias Medicas, Universidade Estadual de Campinas, Campinas, SP, BR.ORCID http://orcid.org/0000-0003-3974-195X
Chester Luiz Galvão CesarFaculdade de Saude Publica, Universidade de Sao Paulo, Sao Paulo, SP, BR.ORCID http://orcid.org/0000-0002-6999-1506
Moisés GoldbaumDepartamento de Medicina Preventiva, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo, SP, BR.ORCID http://orcid.org/0000-0002-8049-7824
Universidade Estadual de Campinas (UNICAMP) · BRUniversidade de São Paulo · BRInstituto de Saúde · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo analyze the use and acquisition of medicines in São Paulo, Brazil, in 2003 and 2015, according to sociodemographic factors, socioeconomic status, and health conditions of the population.

methodsData were obtained from population health surveys "ISA-Capital". Descriptive analysis, bivariate analysis, and logistic regression models were used to evaluate the use of medicines and coverage by the Brazilian Unified Health System (SUS) according to socioeconomic status and health conditions in two periods: 2003 and 2015.

resultsFrom 2003 to 2015, the surveys showed an increase in the income and education level of the study population. There was no increase in the prevalence of chronic diseases and use of medicines from 2003 to 2015. The provision of medicines by SUS was higher in 2015 than in 2003, and the coverage by SUS was higher in the population with lower education level and income in both 2003 and 2015.

conclusionsThe use of medicines, mainly for chronic disease control, did not change over the years, and there was an increase in SUS coverage for medicines during 2003-2015 in all population groups, with a greater impact on the lower socioeconomic status population. The programs of the provision of medicines implanted since 2003 had influenced the greater SUS coverage for medicines and in the reduction of inequalities in access to medicines.

Indexed as

Delivery of Health CareBrazilChronic DiseaseCross-Sectional StudiesHumansPrevalenceSocioeconomic Factors

Identifiers

PMID34287478
PMCPMC8266172
OpenAlexW3182804143

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.